Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL®
Clinical trial NCT00258895 · COMPLETED
Trial details
- NCT number
- NCT00258895
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-03-01
- Primary completion
- 2006-12-01
- Enrollment
- 649
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.